MRx-109

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameMRx-109
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMyeloRx LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMyeloRx LLC
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A